Company / Shareholders' Equity
Strata Critical Medical, Inc. Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$221.9M
FY2025
5-year range
$11.1M / $291.4M
FY2021-FY2025
Trend
-5.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has declined for 3 consecutive years, from $291M in FY2022 to $222M in FY2025.
Based on SEC 10-K filings.
$222M in FY2025 with a 3-year CAGR of -8.7%.
Declined from $274M to $222M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -8.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Strata Critical Medical, Inc.'s shareholders' equity has declined for 3 consecutive years.
- 3-year CAGR of -8.7%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 5.3% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $221.9M | -5.3% |
| FY2024 | $234.3M | -14.6% |
| FY2023 | $274.5M | -5.8% |
| FY2022 | $291.4M | +2529.7% |
| FY2021 | $11.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026